Ponatinib
CAS 943319-70-8
Overview
Ponatinib works to stop cancer cells from growing to treat chronic myelogenous leukemia and acute lymphoblastic leukemia
Anant Labs manufacture and furnish high quality Ponatinib impurities for global markets. Our Ponatinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS943319-70-8
Mol. FormulaC29H27F3N6O
Mol. Weight532.57 g/mol
IUPAC3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
SMILESCC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5
InChIInChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)
InChI KeyPHXJVRSECIGDHY-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
PONATINIB943319-70-8AP24534AP 24534AP-24534ponatinibum4340891KFS3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamideCHEBI:78543DTXSID50241426
